Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Douglas Errington"'
Autor:
Syed Zameer Ul Hassan, Douglas Errington, Rumana Hussain, Vivian W. M. Ho, Andrzej Kacperek, Heinrich Heimann
Publikováno v:
Eye (Lond)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de790f1bda06f640aa1bd0a265e606e2
https://europepmc.org/articles/PMC6707222/
https://europepmc.org/articles/PMC6707222/
Publikováno v:
British Journal of Ophthalmology. 98:484-487
Background/Aims A retrospective service evaluation to report on recurrence of iris melanoma after proton beam therapy (PBT). Methods The cohort comprised 150 consecutive eyes with iris melanoma treated with proton beam radiotherapy. Treatment consist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94424e9056bf6c91f2e29cabfcc955f3
https://doi.org/10.1136/bjophthalmol-2013-303321
https://doi.org/10.1136/bjophthalmol-2013-303321
Autor:
Julie O’Hagan, Farida Alam, Helen Flint, Benjamin Hall, Joanne Cliff, Helen Innes, Nicky Thorp, Andrea Law, Eliyaz Ahmed, Richard J. Jackson, Douglas Errington, Allison Hall, Ajay Ashok Bhojwani, Zaf Malik, S O'Reilly, Shaun Tolan, Carlo Palmieri, Silvia Cicconi, Khizar Hayat, Helen Wong
Publikováno v:
Journal of Clinical Oncology. 37:e12108-e12108
e12108 Background: Neoadjuvant (NA) HER2 blockade with trastuzumab (T) and pertuzumab (P) results in pathological complete response (pCR) rates of 39% to 62%. Diarrhoea is reported in up to 73% of cases. No real-world studies have explored the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cfd576a78e81ce9b3a4a9cb6ae114eb
https://doi.org/10.1200/jco.2019.37.15_suppl.e12108
https://doi.org/10.1200/jco.2019.37.15_suppl.e12108
Autor:
Helen Flint, Allison Hall, Carlo Palmieri, Douglas Errington, Silvia Cicconi, Zaf Malik, Julie O'Hagen, Joanne Cliff, Helen Wong, Benjamin Hall, Helen Innes, Ajay Ashok Bhojwani, Nicky Thorp, Andrea Law, Richard J. Jackson, Eliyaz Ahmed, Farida Alam, S O'Reilly, Shaun Tolan, Khizar Hayat
Publikováno v:
Journal of Clinical Oncology. 37:e12559-e12559
e12559 Background: Platinum based regimens in the neoadjuvant (NA) setting for triple negative breast cancer (TNBC) have resulted in a significant increase in the pathological response (pCR) rate but at the cost of worse hematological toxicities. Des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e66fda7a62e5f9cfb4380c3b99d389c
https://doi.org/10.1200/jco.2019.37.15_suppl.e12559
https://doi.org/10.1200/jco.2019.37.15_suppl.e12559
Autor:
R. Douglas Errington, Heinrich Heimann, Andrzej Kacperek, Helen Kalirai, Rumana Hussain, Bertil Damato, Sarah E. Coupland, Carl Groenewald
Publikováno v:
OPHTHALMOLOGY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2013e4140a86279ebfa50dbb953d7d
https://pubmed.ncbi.nlm.nih.gov/27324683
https://pubmed.ncbi.nlm.nih.gov/27324683
Autor:
Richard Shaw, Douglas Errington, Simon N. Rogers, P. Magennis, Julia A. Woolgar, David Vaughan, James S. Brown, D.N. Sutton, Derek Lowe
Publikováno v:
Oral oncology
The main aims of this article are to report the overall and disease-specific survival of a consecutive series of patients presenting with oral cancer from 1992 to 2002 and to relate survival to clinical and pathological factors. The article uses popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da87f72894d0a19e34931d31396fdbd
https://doi.org/10.1016/j.oraloncology.2008.05.008
https://doi.org/10.1016/j.oraloncology.2008.05.008
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:385-391
Purpose To report on local tumor control after 106 Ru brachytherapy for choroidal melanoma. Methods and Materials A total of 458 patients with choroidal melanoma were treated at a single institution between January 1993 and December 2001. The tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34c3679d37dae110788a9a84d72a10f7
https://doi.org/10.1016/j.ijrobp.2005.02.017
https://doi.org/10.1016/j.ijrobp.2005.02.017
Autor:
Martin A. Sheen, Andrzej Kacperek, Mona Chopra, Ian R. Campbell, R. Douglas Errington, Bertil Damato
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:109-115
Purpose: To report on outcomes after proton beam radiotherapy of iris melanoma. Methods and Materials: Between 1993 and 2004, 88 patients with iris melanoma received proton beam radiotherapy, with 53.1 Gy in 4 fractions. Results: The patients had a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47acb3f9730136ecb4f954e3363db7eb
https://doi.org/10.1016/j.ijrobp.2005.01.050
https://doi.org/10.1016/j.ijrobp.2005.01.050
Autor:
Dawn Roberts, Andrzej Kacperek, R. Douglas Errington, Lazaros Konstantinidis, Bertil Damato, Heinrich Heimann
Publikováno v:
The British journal of ophthalmology. 99(2)
Background Collateral damage to upper eyelid margin during proton beam radiotherapy (PBR) for choroidal melanoma may cause squamous metaplasia of the tarsal conjunctiva with keratinisation, corneal irritation, discomfort and, rarely, corneal perforat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be51c77365a6cbf33751c1faa6be2e6
https://pubmed.ncbi.nlm.nih.gov/25138766
https://pubmed.ncbi.nlm.nih.gov/25138766
Publikováno v:
International journal of radiation oncology, biology, physics. 63(2)
To report on conservation of visual acuity after Ruthenium(106) (Ru-106) brachytherapy of choroidal melanoma.This study was a noncomparative interventional case series of 458 patients with choroidal melanoma treated at a single center between January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479381eace8e551376634266a299bca6
https://pubmed.ncbi.nlm.nih.gov/15990248
https://pubmed.ncbi.nlm.nih.gov/15990248